{"id":81361,"date":"2024-10-25T11:13:10","date_gmt":"2024-10-25T09:13:10","guid":{"rendered":"https:\/\/aktuelles.uni-frankfurt.de\/?p=81361"},"modified":"2024-10-25T11:14:47","modified_gmt":"2024-10-25T09:14:47","slug":"loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins","status":"publish","type":"post","link":"https:\/\/aktuelles.uni-frankfurt.de\/en\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/","title":{"rendered":"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins"},"content":{"rendered":"<p><strong>Hessian state program provides \u20ac3 million in funding for LOEWE top professorship at Goethe University Frankfurt<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"650\" height=\"450\" src=\"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg\" alt=\"\" class=\"wp-image-37003\" srcset=\"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg 650w, https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud-300x208.jpg 300w\" sizes=\"(max-width: 650px) 100vw, 650px\" \/><figcaption class=\"wp-element-caption\">Photo: Uwe Dettmar<\/figcaption><\/figure>\n\n\n\n<p>Prof. Ivan \u0110iki\u0107, an expert in endogenous quality control mechanisms and their therapeutic use, has been awarded a top LOEWE professorship at Goethe University Frankfurt. The state of Hesse\u2019s LOEWE research funding program will make available \u20ac3 million over a period of five years for the development of novel drugs that break down disease-relevant proteins in the body in a targeted manner.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Leibniz Prize Winner<\/h2>\n\n\n\n<p>\u201cProf. \u0110iki\u0107 is one of the most cited researchers in the life sciences, and is internationally renowned. His scientific work has received numerous awards \u2013 including the Leibniz Prize. He has already succeeded three times in acquiring one of the European Research Council\u2019s coveted Advanced Grants,\u201d said Hessian Science Minister Timon Gremmels, adding that, \u201cProf. \u0110iki\u0107&#8217;s research activities are not only greatly important for Frankfurt\u2019s strategic profiling, but also for interdisciplinary networking in the field of research into the causes of and treatment options for diseases like cancer.\u201d<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Focus on active substances against cancer<\/h2>\n\n\n\n<p>Prof. \u0110iki\u0107\u2019s laboratory pursues a promising approach to developing innovative and efficient drugs, with the LOEWE top professorship honing in on the development of active substances against cancer. The focus lies on so-called ProxiDrugs (proximity-inducing drugs), which enable the targeted degradation of disease-relevant proteins in the cell. This opens up new therapeutic options for a variety of diseases, including those previously considered untreatable. In the cell, protein degradation is primarily controlled by the ubiquitin system, within which the small protein ubiquitin is linked to another protein as part of a precisely regulated process, which is then marked for degradation. The pharmacological reprogramming of this machinery enables the targeted degradation of unwanted, disease-relevant proteins.<\/p>\n\n\n\n<p>Goethe University President Prof. Enrico Schleiff: \u201cProf. \u0110iki\u0107 and his multidisciplinary team are researching the molecular basis of life to discover pathological changes that lead to the development of human diseases such as cancer, neurodegeneration and infections. His research on ProxiDrugs is essential in the fight against cancer. We are delighted that, with the support of the state of Hesse and the LOEWE top professorship, we can continue to keep this renowned and esteemed researcher at Goethe University.\u201d<\/p>\n\n\n\n<p>Ivan \u0110iki\u0107 studied medicine at the University of Zagreb, obtained his doctorate at New York University and then founded his first independent group at the Ludwig Institute for Cancer Research in Uppsala. He was appointed to Goethe University Frankfurt in 2002, where he has served as director of the Institute of Biochemistry II since 2009. From 2009 to 2013, he was founding director of the Buchmann Institute for Molecular Life Sciences. In 2018, \u0110iki\u0107 was appointed a fellow of the Max Planck Institute of Biophysics in Frankfurt. He is co-founder and board member of the LOEWE Center Frankfurt Cancer Institute, spokesperson of the Federal Ministry of Education and Research-funded future cluster PROXIDRUGS and the German Research Foundation-funded Collaborative Research Center 1177 on selective autophagy as well as co-spokesperson of the ENABLE cluster project. His biomedical research has been honored with numerous awards, including the Gottfried Wilhelm Leibniz Prize in 2013. He is an elected member of the German National Academy of Sciences Leopoldina, the European Molecular Biology Organization (EMBO) and the American Academy of Arts and Sciences.<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-background\" style=\"background-color:#eeeeee\"><strong>What are LOEWE professorships?<br><\/strong><br>LOEWE top professorships provide excellent, internationally recognized researchers with an endowment between \u20ac1.5 and 3 million for five years.<br><br>LOEWE Start Professorships offer up to \u20ac2 million in funding and are aimed at excellent researchers at an early stage of their career, who are recruited or retained in the state of Hesse for a period of six years.<br><br>LOEWE Transfer Professorships, which are currently in the pilot phase, support researchers in further developing application-oriented results in exchange with partners from practice in a manner that allows these results to successfully contribute to solving social, cultural or economic issues. The funding amounts to up to \u20ac1 million to endow a professorship for five years.<\/p>\n\n\n\n<p><em><a href=\"https:\/\/wissenschaft.hessen.de\/presse\/prof-dr-ivan-dikic-entwickelt-medikamente-zum-abbau-krankheitsrelevanter-proteine\" target=\"_blank\" rel=\"noreferrer noopener\">Source: Hessian Ministry of Science and Research, Arts and Culture, October 21, 2024<\/a><\/em><\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Hessian state program provides \u20ac3 million in funding for LOEWE top professorship at Goethe University Frankfurt Prof. Ivan \u0110iki\u0107, an expert in endogenous quality control mechanisms and their therapeutic use, [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":37003,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[126,254],"tags":[243],"post_folder":[],"class_list":["post-81361","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-english","category-research","tag-biochemistry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins | Aktuelles aus der Goethe-Universit\u00e4t Frankfurt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aktuelles.uni-frankfurt.de\/en\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins | Aktuelles aus der Goethe-Universit\u00e4t Frankfurt\" \/>\n<meta property=\"og:description\" content=\"Hessian state program provides \u20ac3 million in funding for LOEWE top professorship at Goethe University Frankfurt Prof. Ivan \u0110iki\u0107, an expert in endogenous quality control mechanisms and their therapeutic use, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aktuelles.uni-frankfurt.de\/en\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/\" \/>\n<meta property=\"og:site_name\" content=\"Aktuelles aus der Goethe-Universit\u00e4t Frankfurt\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-25T09:13:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-25T09:14:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"650\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"-\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"-\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/\"},\"author\":{\"name\":\"-\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#\\\/schema\\\/person\\\/8e55ea338fb65d1ce87a91565d1f1739\"},\"headline\":\"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins\",\"datePublished\":\"2024-10-25T09:13:10+00:00\",\"dateModified\":\"2024-10-25T09:14:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/\"},\"wordCount\":678,\"publisher\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg\",\"keywords\":[\"Biochemistry\"],\"articleSection\":[\"English\",\"Research\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/\",\"url\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/\",\"name\":\"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins | Aktuelles aus der Goethe-Universit\u00e4t Frankfurt\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg\",\"datePublished\":\"2024-10-25T09:13:10+00:00\",\"dateModified\":\"2024-10-25T09:14:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/#primaryimage\",\"url\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg\",\"contentUrl\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg\",\"width\":650,\"height\":450,\"caption\":\"Der Biochemiker Ivan Dikic wurde in die Amerikanische Akademie der Wissenschaften gew\u00e4hlt\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/english\\\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#website\",\"url\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/\",\"name\":\"Aktuelles aus der Goethe-Universit\u00e4t Frankfurt\",\"description\":\"Aktuelles aus der Goethe-Universit\u00e4t | Neues aus Forschung, Lehre, Studium\",\"publisher\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#organization\",\"name\":\"Goethe-Universit\u00e4t\",\"url\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/800px-Goethe-Logo.png\",\"contentUrl\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/800px-Goethe-Logo.png\",\"width\":800,\"height\":436,\"caption\":\"Goethe-Universit\u00e4t\"},\"image\":{\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/#\\\/schema\\\/person\\\/8e55ea338fb65d1ce87a91565d1f1739\",\"name\":\"-\",\"description\":\"Dieser Beitrag wurde von der Online-Redaktion ver\u00f6ffentlicht. Wenn der Beitrag von einem Gastautoren verfasst wurde, findet sich dieser Hinweis am Ende des jeweiligen Artikels.\",\"sameAs\":[\"http:\\\/\\\/aktuelles.uni-frankfurt.de\\\/autoren\"],\"url\":\"https:\\\/\\\/aktuelles.uni-frankfurt.de\\\/en\\\/author\\\/redaktion\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins | Aktuelles aus der Goethe-Universit\u00e4t Frankfurt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aktuelles.uni-frankfurt.de\/en\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/","og_locale":"en_GB","og_type":"article","og_title":"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins | Aktuelles aus der Goethe-Universit\u00e4t Frankfurt","og_description":"Hessian state program provides \u20ac3 million in funding for LOEWE top professorship at Goethe University Frankfurt Prof. Ivan \u0110iki\u0107, an expert in endogenous quality control mechanisms and their therapeutic use, [&hellip;]","og_url":"https:\/\/aktuelles.uni-frankfurt.de\/en\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/","og_site_name":"Aktuelles aus der Goethe-Universit\u00e4t Frankfurt","article_published_time":"2024-10-25T09:13:10+00:00","article_modified_time":"2024-10-25T09:14:47+00:00","og_image":[{"width":650,"height":450,"url":"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg","type":"image\/jpeg"}],"author":"-","twitter_card":"summary_large_image","twitter_misc":{"Written by":"-","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/#article","isPartOf":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/"},"author":{"name":"-","@id":"https:\/\/aktuelles.uni-frankfurt.de\/#\/schema\/person\/8e55ea338fb65d1ce87a91565d1f1739"},"headline":"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins","datePublished":"2024-10-25T09:13:10+00:00","dateModified":"2024-10-25T09:14:47+00:00","mainEntityOfPage":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/"},"wordCount":678,"publisher":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/#organization"},"image":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/#primaryimage"},"thumbnailUrl":"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg","keywords":["Biochemistry"],"articleSection":["English","Research"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/","url":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/","name":"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins | Aktuelles aus der Goethe-Universit\u00e4t Frankfurt","isPartOf":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/#primaryimage"},"image":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/#primaryimage"},"thumbnailUrl":"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg","datePublished":"2024-10-25T09:13:10+00:00","dateModified":"2024-10-25T09:14:47+00:00","breadcrumb":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/#primaryimage","url":"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg","contentUrl":"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2019\/04\/beitrag_pm_076_Dikic-American-Acadamy_ud.jpg","width":650,"height":450,"caption":"Der Biochemiker Ivan Dikic wurde in die Amerikanische Akademie der Wissenschaften gew\u00e4hlt"},{"@type":"BreadcrumbList","@id":"https:\/\/aktuelles.uni-frankfurt.de\/english\/loewe-top-professorship-prof-ivan-dikic-develops-drugs-that-break-down-disease-relevant-proteins\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/aktuelles.uni-frankfurt.de\/"},{"@type":"ListItem","position":2,"name":"LOEWE top professorship: Prof. Ivan \u0110iki\u0107 develops drugs that break down disease-relevant proteins"}]},{"@type":"WebSite","@id":"https:\/\/aktuelles.uni-frankfurt.de\/#website","url":"https:\/\/aktuelles.uni-frankfurt.de\/","name":"Aktuelles aus der Goethe-Universit\u00e4t Frankfurt","description":"Aktuelles aus der Goethe-Universit\u00e4t | Neues aus Forschung, Lehre, Studium","publisher":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aktuelles.uni-frankfurt.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/aktuelles.uni-frankfurt.de\/#organization","name":"Goethe University Frankfurt","url":"https:\/\/aktuelles.uni-frankfurt.de\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/aktuelles.uni-frankfurt.de\/#\/schema\/logo\/image\/","url":"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2022\/03\/800px-Goethe-Logo.png","contentUrl":"https:\/\/aktuelles.uni-frankfurt.de\/wp-content\/uploads\/2022\/03\/800px-Goethe-Logo.png","width":800,"height":436,"caption":"Goethe-Universit\u00e4t"},"image":{"@id":"https:\/\/aktuelles.uni-frankfurt.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/aktuelles.uni-frankfurt.de\/#\/schema\/person\/8e55ea338fb65d1ce87a91565d1f1739","name":"-","description":"Dieser Beitrag wurde von der Online-Redaktion ver\u00f6ffentlicht. Wenn der Beitrag von einem Gastautoren verfasst wurde, findet sich dieser Hinweis am Ende des jeweiligen Artikels.","sameAs":["http:\/\/aktuelles.uni-frankfurt.de\/autoren"],"url":"https:\/\/aktuelles.uni-frankfurt.de\/en\/author\/redaktion\/"}]}},"_links":{"self":[{"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/posts\/81361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/comments?post=81361"}],"version-history":[{"count":0,"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/posts\/81361\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/media\/37003"}],"wp:attachment":[{"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/media?parent=81361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/categories?post=81361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/tags?post=81361"},{"taxonomy":"post_folder","embeddable":true,"href":"https:\/\/aktuelles.uni-frankfurt.de\/en\/wp-json\/wp\/v2\/post_folder?post=81361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}